Calcitonin actions on kidney
Yasuda, S.; Ono, K.; Wada, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 10): 207-210
2005
ISSN/ISBN: 0047-1852 PMID: 16279632 Document Number: 593702
Document emailed within 1 workday
Related Documents
Szücs, J.; Steczek, K. 1978: Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis Orvosi Hetilap 119(20): 1220-1224Gokin, A.P.; Jennings, L.J.; Mawe, G.M. 1996: Actions of calcitonin gene-related peptide in guinea pig gallbladder ganglia American Journal of Physiology 271(5 Pt 1): G876-G883
Hosking, D.J.; Gilson, D. 1984: Comparison of the renal and skeletal actions of calcitonin in the treatment of severe hypercalcaemia of malignancy Quarterly Journal of Medicine 53(211): 359-368
Wada, S.; Yasuda, S. 2006: Molecular biology in regulation of kidney functions: Calcitonin Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 2): 238-241
Jerzmanowska, M.; Lorenc, R. 1981: Abolition by preventive action of calcitonin of vitamin D3-stimulated gluconeogenesis in rat kidney Acta Physiologica Polonica 32(3): 293-302
Ogata, E.; Kishikawa, T.; Nishimoto, K. 1974: Elevation of adenylate energy charge in the rat kidney caused by calcitonin and the effect of succinate Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 36(8-9): 346
Ishida, M.; Yamada, M. 1991: Calcitonin for therapy of renal osteodystrophy due to long-term hemodialysis in patients with chronic kidney failure Nihon Rinsho. Japanese Journal of Clinical Medicine 49 Suppl: 725-731
Yiin, K.T.; Chiang, C.D.; Chen, C.F.; Wang, S.J.; Lin, W.H.; Guu, C.J.; Lee, H.K.; Jih, K.S.; Lin, T.M.; Huang, W.L. 1987: The serum levels of human calcitonin (hCT) and salmon calcitonin (sCT) in lung cancer patients Zhonghua Yi Xue Za Zhi 40(6): 517-522
Ziegler, R.; Raue, F. 1984: Variations of plasma calcitonin levels measured by radioimmunoassay systems for human calcitonin Biomedicine and PharmacoTherapy 38(5): 245-251
Suva, L.J.; Flannery, M.S.; Caulfield, M.P.; Findlay, D.M.; Jüppner, H.; Goldring, S.R.; Rosenblatt, M.; Chorev, M. 1997: Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor Journal of Pharmacology and Experimental Therapeutics 283(2): 876-884
Dopplet, S.H.; Talmage, R.V. 1976: Calcitonin and the bone fluid compartment: effect of calcitonin and/or parathyroid hormone on plasma radiocalcium changes Clinical Orthopaedics and Related Research 118: 242-250
Saller, B.; Goerges, R.; Reinhardt, W.; Haupt, K.; Janssen, O.E.; Mann, K. 2002: Sensitive Calcitonin Measurement by Two-site Immunometric Assays: Implications for Calcitonin Screening in Nodular Thyroid Disease Clinical Laboratory 48(3-4): 191-200
Galán Galán, F.; Garrido Peralta, M. 1982: Calcitonin as a tumor marker. II. Calcitonin in non-thyroid tumors Revista Clinica Espanola 165(2): 73-76
Lamari, Y.; Tahri, E.H.; Collignon, H.; Garel, J.M. 1994: Steroid hormones and retinoic acid interact in the regulation of calcitonin and calcitonin gene-related peptide secretion and messenger ribonucleic acid levels in CA-77 C cells Cellular and Molecular Biology 40(4): 541-550
2012: Physician disciplinary actions by state. Ranked by total board actions in 2011 Modern healthcare 42(43): 45
Aoyagi, T.; Wada, T.; Ohuchi, S.; Kawamura, K.; Fukatsu, S.; Umezawa, H. 1984: In vivo actions of bestatin-related compounds in relation to their actions in vitro Biochemistry International 9(5): 643-650
Koda, A.; Nishiyori, T.; Nagai, H.; Matsuura, N.; Tsuchiya, H. 1982: Anti-allergic actions of traditional oriental medicine--actions against types i and IV hypersensitivity reactions Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 80(1): 31-41
Grzybowski, A. 2006: The history of antitobacco actions in the last 500 years. Part. II. Medical actions Przeglad Lekarski 63(10): 1131-1134
Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556
Rodriguez Pizarro, A.N. 2005: Acciones colectivas en el conflicto político colombiano : ¿De guerrilla a grupos terroristas? El caso del ELN - Collective actions in the Colombian political conflict : From guerrilla to terrorist groups? The study of ELN - Actions collectives dans le conflit politique colombien: De la guerilla aux groupes terroristes? Le cas de l'ELN Politica y Sociedad (Madrid) 42(2): 133-147